Gene · 4882
Papers1,917
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 1,917
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cell-Free DNA in Cerebrospinal Fluid Complements the Monitoring Value of Interleukin-10 in Newly Diagnosed Primary Central Nervous System Lymphoma. | J Oncol | 2023 | 36644235 | PubTator, text mining | PubMed |
| International Consensus Guideline on Small for Gestational Age: Etiology and Management From Infancy to Early Adulthood. | Endocr Rev | 2023 | 36635911 | PubTator, text mining | PubMed |
| The Predictive Value of A, B, and C-Type Natriuretic Peptides in People at Risk of Heart Disease: Protocol for a Longitudinal Observational Study. | JMIR Res Protoc | 2023 | 36630163 | PubTator, text mining | PubMed |
| Inflammageing and Cardiovascular System: Focus on Cardiokines and Cardiac-Specific Biomarkers. | Int J Mol Sci | 2023 | 36614282 | PubTator, text mining | PubMed |
| Genetic, DNA methylation, and immune profile discrepancies between early-stage single primary lung cancer and synchronous multiple primary lung cancer. | Clin Epigenetics | 2023 | 36611170 | PubTator, text mining | PubMed |
| Regression of cardiac hypertrophy in health and disease: mechanisms and therapeutic potential. | Nat Rev Cardiol | 2023 | 36596855 | PubTator, text mining | PubMed |
| Whole-exome sequence analysis of anthropometric traits illustrates challenges in identifying effects of rare genetic variants. | HGG Adv | 2023 | 36568030 | PubTator, text mining | PubMed |
| A spatially resolved atlas of the human lung characterizes a gland-associated immune niche. | Nat Genet | 2023 | 36543915 | PubTator, text mining | PubMed |
| DrugCentral 2023 extends human clinical data and integrates veterinary drugs. | Nucleic Acids Res | 2023 | 36484092 | PubTator, text mining | PubMed |
| Localization of natriuretic peptide receptors A, B, and C in healthy and diseased mouse kidneys. | Pflugers Arch | 2023 | 36480070 | PubTator, text mining | PubMed |
| Inhibition of USP1 reverses the chemotherapy resistance through destabilization of MAX in the relapsed/refractory B-cell lymphoma. | Leukemia | 2023 | 36352191 | PubTator, text mining | PubMed |
| Distinct Genetically Determined Origins of Myd88/BCL2-Driven Aggressive Lymphoma Rationalize Targeted Therapeutic Intervention Strategies. | Blood Cancer Discov | 2023 | 36346827 | PubTator, text mining | PubMed |
| A State of Natriuretic Peptide Deficiency. | Endocr Rev | 2023 | 36346821 | PubTator, text mining | PubMed |
| An Aged/Autoimmune B-cell Program Defines the Early Transformation of Extranodal Lymphomas. | Cancer Discov | 2023 | 36264161 | PubTator, text mining | PubMed |
| Transformation of FL into DLBCL with a PMBL gene expression signature. | Blood Adv | 2023 | 36240289 | PubTator, text mining | PubMed |
| Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma. | Blood | 2023 | 36201743 | PubTator, text mining | PubMed |
| Resistance to Bruton tyrosine kinase inhibition in chronic lymphocytic leukaemia and non-Hodgkin lymphoma. | Br J Haematol | 2023 | 36029036 | PubTator, text mining | PubMed |
| Natriuretic peptide pathways in heart failure: further therapeutic possibilities. | Cardiovasc Res | 2023 | 36004816 | PubTator, text mining | PubMed |
| Longitudinal expression profiling identifies a poor risk subset of patients with ABC-type diffuse large B-cell lymphoma. | Blood Adv | 2023 | 35947123 | PubTator, text mining | PubMed |
| Genetic landscapes and curative effect of CAR T-cell immunotherapy in patients with relapsed or refractory DLBCL. | Blood Adv | 2023 | 35901280 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4882/papers?page=12